Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T13:41:23.166Z.
Calculation as of: 2026-10-06T13:41:23.166Z.
Quote observation: 2026-10-06T13:40:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ee881eee59918e8cff759d9372c22030baed04f147f6b571d3011c58a892a573
EARNINGS YIELD
N/A
Market Cap
$88.52M
Earnings Yield
0.86%
TTM Avg
3.26%
3Y Avg
3.22%
5Y Avg
1.83%
Market Cap
$85.60M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$99.48M
Earnings Yield
N/A
TTM Avg
0.56%
3Y Avg
0.56%
5Y Avg
0.56%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | $91.82M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $91.51M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $89.15M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $88.84M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $88.52M | 0.86% | 3.26% | 3.22% | 1.83% |
| CareCloud, Inc. (CCLD)vs › | $87.11M | 3.40% | 2.77% | 2.77% | 8.10% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.60M | N/A | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $99.48M | N/A | 0.56% | 0.56% | 0.56% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.97M | N/A | 39.78% | 39.78% | 39.78% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
